267 related articles for article (PubMed ID: 31646742)
1. Magnetic resonance-guided radiation therapy: A review.
Chin S; Eccles CL; McWilliam A; Chuter R; Walker E; Whitehurst P; Berresford J; Van Herk M; Hoskin PJ; Choudhury A
J Med Imaging Radiat Oncol; 2020 Feb; 64(1):163-177. PubMed ID: 31646742
[TBL] [Abstract][Full Text] [Related]
2. MRI-guided Radiotherapy (MRgRT) for Treatment of Oligometastases: Review of Clinical Applications and Challenges.
Chetty IJ; Doemer AJ; Dolan JL; Kim JP; Cunningham JM; Dragovic J; Feldman A; Walker EM; Elshaikh M; Adil K; Movsas B; Parikh PJ
Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):950-967. PubMed ID: 35901978
[TBL] [Abstract][Full Text] [Related]
3. Medical physics challenges in clinical MR-guided radiotherapy.
Kurz C; Buizza G; Landry G; Kamp F; Rabe M; Paganelli C; Baroni G; Reiner M; Keall PJ; van den Berg CAT; Riboldi M
Radiat Oncol; 2020 May; 15(1):93. PubMed ID: 32370788
[TBL] [Abstract][Full Text] [Related]
4. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
5. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
7. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
[TBL] [Abstract][Full Text] [Related]
8. Technical Radiotherapy Advances - The Role of Magnetic Resonance Imaging-Guided Radiation in the Delivery of Hypofractionation.
Gough J; Hall W; Good J; Nash A; Aitken K
Clin Oncol (R Coll Radiol); 2022 May; 34(5):301-312. PubMed ID: 35305888
[TBL] [Abstract][Full Text] [Related]
9. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results.
Bruynzeel AME; Tetar SU; Oei SS; Senan S; Haasbeek CJA; Spoelstra FOB; Piet AHM; Meijnen P; Bakker van der Jagt MAB; Fraikin T; Slotman BJ; van Moorselaar RJA; Lagerwaard FJ
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1086-1094. PubMed ID: 31419510
[TBL] [Abstract][Full Text] [Related]
11. Intrafraction Motion Management With MR-Guided Radiation Therapy.
Fast MF; Cao M; Parikh P; Sonke JJ
Semin Radiat Oncol; 2024 Jan; 34(1):92-106. PubMed ID: 38105098
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy.
Yadav P; Musunuru HB; Witt JS; Bassetti M; Bayouth J; Baschnagel AM
Radiol Oncol; 2019 Sep; 53(3):362-368. PubMed ID: 31553704
[TBL] [Abstract][Full Text] [Related]
13. A facility for magnetic resonance-guided radiation therapy.
Jaffray DA; Carlone MC; Milosevic MF; Breen SL; Stanescu T; Rink A; Alasti H; Simeonov A; Sweitzer MC; Winter JD
Semin Radiat Oncol; 2014 Jul; 24(3):193-5. PubMed ID: 24931091
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance image guidance in external beam radiation therapy planning and delivery.
Arivarasan I; Anuradha C; Subramanian S; Anantharaman A; Ramasubramanian V
Jpn J Radiol; 2017 Aug; 35(8):417-426. PubMed ID: 28612288
[TBL] [Abstract][Full Text] [Related]
15. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma.
Zaki P; Chuong MD; Schaub SK; Lo SS; Ibrahim M; Apisarnthanarax S
Technol Cancer Res Treat; 2023; 22():15330338231206335. PubMed ID: 37908130
[TBL] [Abstract][Full Text] [Related]
17. Opportunity Is Knocking: The Need to Responsively and Responsibly Integrate Therapeutic MRI into Radiation Therapy.
Erler D; D'Alimonte L; Campbell M
J Med Imaging Radiat Sci; 2018 Mar; 49(1):16-17. PubMed ID: 30479281
[No Abstract] [Full Text] [Related]
18. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers.
Lavigne D; Ng SP; O'Sullivan B; Nguyen-Tan PF; Filion E; Létourneau-Guillon L; Fuller CD; Bahig H
Curr Oncol; 2022 Oct; 29(11):8302-8315. PubMed ID: 36354715
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance-guided radiotherapy feasibility in elderly cancer patients: proposal of the MASTER scoring system.
Boldrini L; Colloca GF; Villani E; Chiloiro G; Bellieni A; Manfrida S; Cellini F; Gambacorta MA; Valentini V
Tumori; 2021 Feb; 107(1):26-31. PubMed ID: 32410505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
